The 4th Lipid Nanoparticle Development Summit Europe returns to Berlin in October 2025 as Europe’s most comprehensive forum dedicated to the end-to-end development of LNPs to enable progress of potent, stable and scalable drug product formulations into the clinic and beyond.

LNPs remain the leading drug delivery vehicle for global biopharma. Yet five years after their COVID-19 breakthrough, their potential beyond infectious diseases, particularly in oncology and novel therapeutics, still demands validation. With intense R&D, evolving regulation, and rising investment in European development, momentum to expand LNP utility has never been stronger.

Uniting 80+ LNP leaders from the likes of Sanofi, NeoVac, CureVac, and more, this unmissable three-day event will showcase cutting-edge lipid designs, novel preclinical insights, scalable GMP strategies, and never-seen-before data.

Join your peers in LNP discovery, formulation, R&D, analytical and manufacturing for an unrivalled learning and networking opportunity to dive deep into the industry’s biggest delivery challenges towards safer LNP formulations to patients faster.